Preoperative low molecular weight: Heparin as venous thromboembolism prophylaxis in patients at risk for prosthetic infection after knee arthroplasty

Infection Control and Hospital Epidemiology

Volumn 26, Issue 12, 2005, Pages 903-909

  Asensio, Angel ^a   Ramos, Antonio ^a   Múñez, Elena ^a   Vilanova, José L ^a   Torrijos, Pedro ^a   García, Fernando J ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; HUMAN; INFECTION RISK; KNEE ARTHROPLASTY; MALE; PREOPERATIVE TREATMENT; PROSTHESIS INFECTION; RISK FACTOR; SURGICAL INFECTION; VENOUS THROMBOEMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT, KNEE; CASE-CONTROL STUDIES; CHEMOPREVENTION; COHORT STUDIES; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; KNEE PROSTHESIS; MALE; MIDDLE AGED; PREOPERATIVE CARE; PROSTHESIS-RELATED INFECTIONS; SURGICAL WOUND INFECTION; VENOUS THROMBOSIS;

EID: 30644473925     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/505451     Document Type: Article

References (24)

1. Taylor S, Pearce P, McKenzie M, Taylor G. Wound infection after joint arthroplasty: effect of extended wound surveillance on wound infection rates. Can J Surg 1994;37:217-220.
2. Gaine WJ, Ramamohan NA, Hussein NA, Hullin MG, McCreath SW. Wound infection in hip and knee arthroplasty. J Bone Joint Surg Br 2000;82(B):561-565.
3. Peersman G, Laskin R, Davis J, Peterson M. Infection in total knee replacement: a retrospective review of 6,489 total knee replacements. Clin Orthop 2001;392:15-23.
4. Friedman C, Sturm LK, Chenoweth C. Electronic chart review as an aid to postdischarge surgical site surveillance: increased case finding. Am J Infect Control 2001;29:329-332.
5. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) system report: data summary from January 1992 to June 2002, issued August 2002. Am J Infect Control 2002;30:458-475.
6. Kreder HJ, Grosso P, Williams JI, et al. Provider volume and other predictors of outcome after total knee arthroplasty: a population study in Ontario. Can J Surg 2003;46:15-22.
7. Brandt C, Hansen S, Sohr D, Daschner F, Rüden, Gastmeier P. Finding a method for optimizing risk adjustment when comparing surgical-site infection rates. Infect Control Hosp Epidemiol 2004;25:313-318.
8. Thomas C, Cadwallader HL, Riley TV. Surgical-site infections after orthopaedic surgery: statewide surveillance using linked administrative databases. J Hosp Infect 2004;57:25-30.
9. Sculco TP. The economic impact of infected joint arthroplasty. Orthopedics 1995;18:871-873.
10. Zufferey P, Laporte S, Quenet S, et al. Optimal low-molecular-weight heparin regimen in major orthopaedic surgery: a meta-analysis of randomised trials. Thromb Haemost 2003;90:654-661.
11. Raskob GE, Hirsh J. Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery. Chest 2003;124:379S-385S.
12. Strebel N, Prins M, Agnelly G, Büller R. Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery? Arch Intern Med 2002;162:1451-1456.
13. Saleh K, Olson M, Resig S, et al. Predictors of wound infection in hip and knee joint replacement: results from a 20 year surveillance program. J Orthop Res 2002;20:506-515.
14. Minnema B, Vearncombe M, Augustin A, Gollish G, Simor AE. Risk factors for surgical-site infection following primary total knee arthroplasty. Infect Control Hosp Epidemiol 2004;25:477-480.
15. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992;13:606-608.
16. Hosmer DV, Lemeshow S. Model-building strategies and methods for logistic regression. In: Hosmer DV, ed. Applied Logistic Regression. New York: Wiley and Sons; 1989:82-134.
17. Gordon SM, Culver DH, Simmonds BP, Jarvis WR. Risk factors for wound infection after total knee arthroplasty. Am J Epidemiol 1990;131:905-916.
18. Rasul AT Jr, Tsukayama D, Gustilo RB. Effect of time of onset and depth of infection on the outcome of total knee arthroplasty infections. Clin Orthop 1991;273:98-104.
19. Sanderson PJ. Infection in orthopedic implants. J Hosp Infect 1991;18 (suppl A):367-375.
20. Geubbels EL, Bakker HG, Houtman P, et al. Promoting quality through surveillance of surgical site infections: five prevention success stories. Am J Infect Control 2004;32:424-430.
21. Rothman KJ, Greenland S. Precision and validity in epidemiologic studies. In: Rothman KJ, Greenland S, eds. Modern Epidemiology, ed. 2. Philadelphia: Lippincott-Raven; 1998.
22. Burns SJ, Dippe SE. Post-operative wound infections detected during hospitalization and after discharge in a community hospital. Am J Infect Control 1982;10:60-65.
23. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for urgical site prevention, 1999. Infect Control Hosp Epidemiol 1999;20:250-278.
24. Garcia-Lechuz J, Alonso P, Goyanes MJ, et al. Infection on joint prosthesis: a clinical and microbiological retrospective study. Enferm Infecc Microbiol Clin 2004;22(suppl 1):121.